en

PRODUCT DETAIL

Lorviqua 100 mg filmom obalené tablety

Code 1380D
MA number EU/1/19/1355/002
Product Form: tbl flm 30x100 mg (blis.OPA/Al/PVC)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01ED Anaplastic lymphoma kinase (ALK) inhibitors
L01ED05 Lorlatinib
Shelf life: 36
Container: blister OPA/Al/PVC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 06.05.2019
Validity: 08.05.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 17.04.2024
eu-flag.png sk-flag.png